Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04420650
Other study ID # BRAINSTIM
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 26, 2020
Est. completion date November 10, 2023

Study information

Verified date September 2023
Source University Hospital Tuebingen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Efforts in curing and preventing obesity and type 2 diabetes (T2D) have been elusive thus far. One reason for that is the lack of understanding of the role of the brain in the development and treatment of the disease. In recent studies, the hypothalamus was identified as part of a brain network including higher cognitive regions that is particularly vulnerable to insulin resistance. Furthermore, the central insulin response in this network predicted food craving and hunger. In this project, transcranial direct current stimulation (tDCS) is implemented as a tool to stimulate brain networks. The investigators hypothesize that stimulating the hypothalamus-cognitive network will enhance insulin sensitivity and reduce food intake, food craving and hunger. Furthermore, the project will provide the unique opportunity to investigate novel mechanisms of insulin resistance in participants who have been extensively metabolically characterized.


Description:

Objectives The overarching aim of the study is to stimulate the hypothalamus-cognitive brain network to improve insulin sensitivity and eating behavior. Specific Objectives 1. Implement tDCS stimulation compared to sham stimulation in overweight and obese adults to assess the impact on eating behavior, cognition and metabolism. 2. Evaluate whether 3-day non-invasive brain stimulation of the hypothalamus-cognitive network has a causal effect on metabolism. 3. Evaluate whether 3-day non-invasive brain stimulation has a significant effect on brain functional connectivity and diffusion parameters.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date November 10, 2023
Est. primary completion date October 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 66 Years
Eligibility Inclusion Criteria: - Body mass index (BMI) between 25.5 and 39.5 kg/m2 - Age between 20 to 66 years of age - Waist circumference = 80 cm for women, = 94 cm for men Exclusion Criteria: - Insufficient knowledge of the German language - Persons who cannot legally give consent - Pregnancy or lactation - History of severe mental or somatic disorders including neurological diseases (incl. epileptic seizures) - Taking psychotropic drugs - Previous bariatric surgery - Acute infection within the last 4 weeks - Hemoglobin values less than 12g/dl for women, less than 14 g/dl for men - Current participation in a lifestyle intervention study or a pharmaceutical study - Contradictions to a MRI measurement (e.g. metal implants)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
transcranial direct current stimulation
anodal or cathodal transcranial direct current stimulation

Locations

Country Name City State
Germany University Clinic Tübingen Tübingen

Sponsors (2)

Lead Sponsor Collaborator
University Hospital Tuebingen German Center for Diabetes Research

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peripheral insulin sensitivity Oral glucose tolerance derived insulin sensitivity based on the Matsuda index 1 day after last intervention tDCS day
Primary Caloric intake (kcal) Free-choice, ad libitum food intake from a standardized breakfast buffet. The caloric intake from fat, carbohydrates and protein will be documented. 1 hour directly after tDCS stimulation
Primary Change in subjective feeling of hunger and food craving On a visual analogue scale, subjective feeling of hunger and food craving will be assessed using a questionnaire. 5 minutes before tDCS stimulation, 5 minutes after tDCS stimulation and 5 minutes after buffet
Secondary Performance during stop-signal task Outcome measures cover direction errors, proportion of successful stops, reaction time on Go trials, and stop signal reaction time (SSRT). task is performed during 25-minutes tDCS stimulation
Secondary Tastiness and healthiness rating of food stimuli Using a computer based task, participants rate food pictures of low caloric and high caloric foods and snacks on a 5-point scale based on subjective tastiness and healthiness. task is performed immediatly after buffet
Secondary Food choice Using a computer based task, participants have to choose food items they preferred to eat compared to a reference food on a 5-point choice scale. The reference (or "neutral") food item is individually determined based the health and taste rating [Scale: 1= not tasty/ not healthy up to 5= very tasty/ very heahlty]. task is performed immediatly after buffet
Secondary Functional connectivity Resting-state functional connectivity of the hypothalamus-cognitive network is assessed by functional magnetic resonance imaging (fMRI) 10 minutes functional MRI measurement performed before and after three day tDCS stimulation
Secondary Diffusion-weighted imaging Diffusion weighted parameter based on MRI measurements 15 minutes MRI measurement performed before and after three day tDCS stimulation
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2